Alnylam Pharmaceuticals (ALNY) Times Interest Earned (2020 - 2025)
Historic Times Interest Earned for Alnylam Pharmaceuticals (ALNY) over the last 6 years, with Q3 2025 value amounting to $8.29.
- Alnylam Pharmaceuticals' Times Interest Earned rose 47047.93% to $8.29 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.63, marking a year-over-year increase of 21639.03%. This contributed to the annual value of -$1.25 for FY2024, which is 4643.31% up from last year.
- As of Q3 2025, Alnylam Pharmaceuticals' Times Interest Earned stood at $8.29, which was up 47047.93% from -$0.4 recorded in Q2 2025.
- In the past 5 years, Alnylam Pharmaceuticals' Times Interest Earned ranged from a high of $8.29 in Q3 2025 and a low of -$7.65 during Q2 2023
- Moreover, its 5-year median value for Times Interest Earned was -$3.71 (2023), whereas its average is -$2.44.
- Per our database at Business Quant, Alnylam Pharmaceuticals' Times Interest Earned tumbled by 13231.58% in 2024 and then surged by 47047.93% in 2025.
- Quarter analysis of 5 years shows Alnylam Pharmaceuticals' Times Interest Earned stood at -$5.28 in 2021, then decreased by 19.31% to -$6.31 in 2022, then surged by 41.09% to -$3.71 in 2023, then rose by 27.35% to -$2.7 in 2024, then soared by 407.16% to $8.29 in 2025.
- Its Times Interest Earned stands at $8.29 for Q3 2025, versus -$0.4 for Q2 2025 and $0.47 for Q1 2025.